US pharmaceuticals group Alimera Sciences has thrown Perth-founded biotech pSivida a lifeline by agreeing to amend its licence and collaboration deal by taking an extra 30 per cent stake, delivering the cash strapped outfit up to $83 million over four years.
- Forums
- ASX - By Stock
- PSD
- from wa business news
PSD
psivida limited
from wa business news
Featured News
Add PSD (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & MD
Charles Armstrong
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online